Phase 3 retatrutide obesity trial data showing up to 30.3% weight loss bolsters LLY’s GLP-1 franchise leadership, analysts say. Truist maintained a Buy rating on Eli Lilly (LLY) with a $1,281 price target after the company reported Phase 3 retatrutide clinical trial data.
Bank of America cuts Boston Scientific’s price target by 35% citing lower medtech valuations and macro pressures. Bank of America reduced Boston Scientific’s (NYSE:BSX) price target to $68 from $105, maintaining a Buy rating. The adjustment follows a review of 34 medtech c
UnitedHealth’s new pharmacy care model and Goldman’s bullish rating highlight confidence in its Medicare Advantage underwriting cycle recovery. Goldman Sachs added UnitedHealth Group (NYSE:UNH) to its US Conviction list on May 1, assigning a Buy rating and a $435 price tar
Globus Medical, Inc. (NYSE:GMED) is one of the best robotic surgery stocks to buy. Wells Fargo cut the price target on Globus Medical, Inc. (NYSE:GMED) to $103 from $104 on May 8, maintaining an Overweight rating on the shares and noting that the company reported fiscal Q1
Bitcoin falls 0.8% to $76,600, retreating from a brief $77,800 peak as broader risk assets rally and AI tokens outperform. Bitcoin declined 0.8% to $76,600 early Tuesday, erasing Monday’s short-lived rebound to $77,800. The pullback suggests a potential lower high in its p
Medtronic plc (NYSE:MDT) is one of the best robotic surgery stocks to buy. Medtronic plc (NYSE:MDT) announced on May 20 its intention to acquire SPR Therapeutics, Inc. (SPR), which is a privately held medical technology company that holds a leading position in temporary, p
Stryker Corporation (NYSE:SYK) is one of the best robotic surgery stocks to buy. Barclays cut the price target on Stryker Corporation (NYSE:SYK) to $394 from $469 on May 4, maintaining an Overweight rating on the shares The firm told investors in a research note tha
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. BofA cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares The firm told investors that after having
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares The firm stated that the compan
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best robotic surgery stocks to buy. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) received several rating updates following the release of its financial results for fiscal Q1 Piper Sandler lifted the price
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.